The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Mysoline 250mg Tablets

Laboratoires SERBPA1777/001/001

Main Information

Trade NameMysoline 250mg Tablets
Active SubstancesPrimidone
Dosage FormTablet
Licence HolderLaboratoires SERB
Licence NumberPA1777/001/001

Group Information

ATC CodeN03AA Barbiturates and derivatives
N03AA03 primidone


License statusAuthorised
Licence Issued01/04/1979
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back